Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk

Cancer Causes and Control

Volumn 21, Issue 9, 2010, Pages 1437-1444

  Zhang, Jianjun ^b   Dhakal, Ishwori B ^a   Lang, Nicholas P ^a   Kadlubar, Fred F ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

Antioxidants; Inflammatory gene; Oxidative stress; Polymorphism; Prostate cancer

Indexed keywords

BETA CAROTENE; BETA CRYPTOXANTHIN; CYCLOOXYGENASE 2; INTERLEUKIN 8; LYCOPENE; SELENIUM;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE 2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 77956950112     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9571-0     Document Type: Article

References (38)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
2. American Cancer Society (2009) Cancer facts & figures. American Cancer Society, Atlanta
3. H Li PW Kantoff E Giovannucci, et al. 2005 Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer Cancer Res 65 2498 2504 10.1158/0008-5472.CAN-04- 3535 1:CAS:528:DC%2BD2MXisFGnsLY%3D 15781667
4. CH van Gils RM Bostick MC Stern JA Taylor 2002 Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene Cancer Epidemiol Biomarkers Prev 11 1279 1284 12433703
5. AM De Marzo VL Marchi JI Epstein WG Nelson 1999 Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis Am J Pathol 155 1985 1992 10595928
6. R Schlaberg DJ Choe KR Brown HM Thaker IR Singh 2009 XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors Proc Natl Acad Sci USA 106 16351 16356 10.1073/pnas.0906922106 1:CAS:528:DC%2BD1MXht1Kqu7zE 19805305
7. LK Dennis CF Lynch JC Torner 2002 Epidemiologic association between prostatitis and prostate cancer Urology 60 78 83 10.1016/S0090-4295(02)01637-0 12100928
8. LK Dennis DV Dawson 2002 Meta-analysis of measures of sexual activity and prostate cancer Epidemiology 13 72 79 10.1097/00001648-200201000-00012 11805589
9. S Mahmud E Franco A Aprikian 2004 Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis Br J Cancer 90 93 99 10.1038/sj.bjc.6601416 1:CAS:528:DC%2BD2cXhtFKgsw%3D%3D 14710213
10. AM De Marzo EA Platz S Sutcliffe, et al. 2007 Inflammation in prostate carcinogenesis Nat Rev Cancer 7 256 269 10.1038/nrc2090 17384581
11. EL Goode CM Ulrich JD Potter 2002 Polymorphisms in DNA repair genes and associations with cancer risk Cancer Epidemiol Biomarkers Prev 11 1513 1530 1:CAS:528:DC%2BD3sXmsF2msA%3D%3D 12496039
12. J Xu SL Zheng A Turner, et al. 2002 Associations between hOGG1 sequence variants and prostate cancer susceptibility Cancer Res 62 2253 2257 1:CAS:528:DC%2BD38Xjt1ejtLk%3D 11956079
13. A Stone LD Ratnasinghe GL Emerson, et al. 2005 CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians Cancer Epidemiol Biomarkers Prev 14 1257 1261 10.1158/1055-9965.EPI-04-0534 1:CAS:528:DC%2BD2MXktFCkt7s%3D 15894682
14. J Zhang IB Dhakal G Greene NP Lang FF Kadlubar 2010 Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants Urology 75 779 785 10.1016/j.urology.2009.08.063 19914697
15. A El-Sohemy A Baylin E Kabagambe A Ascherio D Spiegelman H Campos 2002 Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake Am J Clin Nutr 76 172 179 1:CAS:528:DC%2BD38XltVyhu7o%3D 12081831
16. EA Platz AM De Marzo 2004 Epidemiology of inflammation and prostate cancer J Urol 171 2 Pt 2 S36 S40 10.1097/01.ju.0000108131.43160.77 14713751
17. SL McCarron S Edwards PR Evans, et al. 2002 Influence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res 62 3369 3372 1:CAS:528:DC%2BD38XkslWqsLs%3D 12067976
18. J Bidwell L Keen G Gallagher, et al. 2001 Cytokine gene polymorphism in human disease: on-line databases, supplement 1 Genes Immun 2 61 70 10.1038/sj.gene.6363733 1:CAS:528:DC%2BD3MXjtFKntbk%3D 11393658
19. WG Nelson AM De Marzo TL DeWeese WB Isaacs 2004 The role of inflammation in the pathogenesis of prostate cancer J Urol 172 5 Pt 2 S6 S11 10.1097/01.ju.0000142058.99614.ff 1:CAS:528:DC%2BD2cXps12js7k%3D 15535435 discussion S11-12
20. I Cheng X Liu SJ Plummer LM Krumroy G Casey JS Witte 2007 COX2 genetic variation, NSAIDs, and advanced prostate cancer risk Br J Cancer 97 557 561 10.1038/sj.bjc.6603874 1:CAS:528:DC%2BD2sXptVWjurk%3D 17609663
21. X Zhang X Miao W Tan, et al. 2005 Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 565 576 1:CAS:528:DC%2BD2MXpvVWmsbw%3D 16083713
22. AE Koch PJ Polverini SL Kunkel, et al. 1992 Interleukin-8 as a macrophage-derived mediator of angiogenesis Science 258 1798 1801 10.1126/science.1281554 1:CAS:528:DyaK3sXlslyktg%3D%3D 1281554
23. SJ Kim H Uehara T Karashima M McCarty N Shih IJ Fidler 2001 Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice Neoplasia 3 33 42 10.1038/sj.neo.7900124 1:CAS:528:DC%2BD3MXis1agu7o%3D 11326314
24. K Inoue JW Slaton BY Eve, et al. 2000 Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer Clin Cancer Res 6 2104 2119 1:CAS:528:DC%2BD3cXktVWit78%3D 10815938
25. RW Veltri MC Miller G Zhao, et al. 1999 Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer Urology 53 139 147 10.1016/S0090-4295(98)00455-5 1:STN:280:DyaK1M7gtFKqtg%3D%3D 9886603
26. DS Michaud SE Daugherty SI Berndt, et al. 2006 Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer Cancer Res 66 4525 4530 10.1158/0008-5472.CAN-05-3987 1:CAS:528:DC%2BD28XjsFSlu7k%3D 16618781
27. J Hull A Thomson D Kwiatkowski 2000 Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families Thorax 55 1023 1027 10.1136/thorax.55.12.1023 1:STN:280:DC%2BD3M7hs1aktg%3D%3D 11083887
28. J Zhang I Dhakal A Stone, et al. 2007 Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas Nutr Cancer 59 46 53 1:CAS:528:DC%2BD2sXht1CltrfF 17927501
29. Y Guo X Zhang W Tan, et al. 2007 Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms Pharmacogenet Genomics 17 197 205 10.1097/FPC.0b013e328010bda1 1:CAS:528:DC%2BD2sXjsVSjs74%3D 17460548
30. P Saenz-Lopez R Carretero JM Cozar, et al. 2008 Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer BMC Cancer 8 382 10.1186/1471-2407-8-382 19099590
31. KN Danforth C Rodriguez RB Hayes, et al. 2008 TNF polymorphisms and prostate cancer risk Prostate 68 400 407 10.1002/pros.20694 1:CAS:528: DC%2BD1cXkt1ygu74%3D 18196539
32. SC Moore MF Leitzmann D Albanes, et al. 2009 Adipokine genes and prostate cancer risk Int J Cancer 124 869 876 10.1002/ijc.24043 1:CAS:528: DC%2BD1MXhvVShs78%3D 19035456
33. BL Pierce ML Biggs M DeCambre, et al. 2009 C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older Cancer Causes Control 20 1193 1203 10.1007/s10552-009-9320-4 19267250
34. J Sun M Hedelin SL Zheng, et al. 2004 Interleukin-6 sequence variants are not associated with prostate cancer risk Cancer Epidemiol Biomarkers Prev 13 1677 1679 1:CAS:528:DC%2BD2cXotFWnsrY%3D 15466986
35. JR Stark H Li P Kraft, et al. 2009 Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality Int J Cancer 124 2683 2689 10.1002/ijc.24241 1:CAS:528:DC%2BD1MXltlegu74%3D 19189403
36. Willett WC, Lenart E (1998) Reproducibility and validity of food-frequency questionnaire. In: Willett WC (ed) Nutritional epidemiology, 2nd edn. Oxford University Press, New York, NY, pp 101-147
37. C Hughes A Murphy C Martin O Sheils J O'Leary 2005 Molecular pathology of prostate cancer J Clin Pathol 58 673 684 10.1136/jcp.2002.003954 1:CAS:528:DC%2BD2MXntV2luro%3D 15976331
38. GW Comstock AJ Alberg KJ Helzlsouer 1993 Reported effects of long-term freezer storage on concentrations of retinol, beta-carotene, and alpha-tocopherol in serum or plasma summarized Clin Chem 39 1075 1078 1:CAS:528:DyaK3sXkvFSgtL0%3D 8504540